Australia Insulin Delivery Devices Market Size (2024 - 2029)

The Australia Insulin Delivery Devices Market is projected to experience growth over the forecast period, driven by the increasing need for effective diabetes management solutions. The market's expansion is influenced by the shift from traditional insulin delivery methods, such as pens and syringes, to more advanced insulin pumps, which offer enhanced efficacy and improve patient compliance. The COVID-19 pandemic highlighted the challenges in diabetes management, underscoring the importance of maintaining robust supply chains and access to essential diabetes care resources. This growth trajectory reflects the ongoing efforts to address the healthcare needs of the diabetic population in Australia, ensuring better management of this chronic condition.

Market Size of Australia Insulin Delivery Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Australia Insulin Delivery Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 705.52 Million
Market Size (2029) USD 794.35 Million
CAGR (2024 - 2029) 2.40 %

Major Players

Australia Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Australia Insulin Delivery Devices Market Analysis

The Australia Insulin Delivery Devices Market size is estimated at USD 705.52 million in 2024, and is expected to reach USD 794.35 million by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029).

During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from SARS-CoV-2 infection. Throughout the COVID-19 pandemic, the effects of diabetes worsened with infection and infection-induced new-onset diabetes in both adults and children. Diabetes self-management, follow-up care, and glycemic management were disrupted during the COVID-19 pandemic, which recognized the need for proper guidelines and protocols to ensure successful continuity of management and follow-up care for people with existing and new-onset diabetes.

Diabetes is a chronic condition characterized by high blood glucose levels caused by the inability to produce insulin or use insulin effectively, or both. The main types of diabetes are type 1 diabetes and type 2 diabetes. For a patient with type 1 diabetes, insulin therapy is important for replacing the insulin the body doesn't produce. People with type 2 diabetes or gestational diabetes need insulin therapy if other treatments, such as diabetes medications and other lifestyle changes, cannot keep blood glucose levels within the desired range. Diabetes treatment aims to maintain healthy blood glucose levels to prevent short- and long-term complications, such as cardiovascular disease, kidney disease, blindness, and lower limb amputation.

Diabetes has a significant and often preventable impact on the health and well-being of the Australian population. The Australian Government reviews processes and infrastructure to ensure adequate supplies and supply chains of essential medications, glucose monitoring equipment, insulin pump consumables, and measures to manage diabetes. People with diabetes who have disabilities require specialized assistance managing their diabetes, including accessing health services, administering insulin, and operating diabetes devices.

The overall CAGR is impacted by consumers switching from insulin pens and syringes to insulin pumps due to increased efficacy and patient compliance.

Australia Insulin Delivery Devices Industry Segmentation

There are different ways to inject insulin into a patient's body, using syringes, pens, pumps, and jet injectors, giving them various options for insulin delivery. The Australia Insulin Delivery Devices Market is segmented into insulin pumps, insulin syringes, disposable insulin pens, insulin cartridges in reusable pens, and insulin jet injectors. The report offers the value (in USD million) and volume (in Units million) for the above segments.

Insulin Pumps
Insulin Pump Devices
Insulin Pump Reservoirs
Insulin Infusion sets
Insulin Pens
Cartridges in reusable pens
Disposable insulin pens
Need A Different Region Or Segment?
Customize Now

Australia Insulin Delivery Devices Market Size Summary

The Australia Insulin Delivery Devices Market is poised for growth, driven by the increasing prevalence of diabetes and the shift towards more efficient insulin delivery methods. The market is characterized by a transition from traditional insulin pens and syringes to advanced insulin pumps, which offer enhanced efficacy and patient compliance. This shift is supported by technological advancements in insulin delivery devices, such as the development of insulin pumps that provide continuous and on-demand insulin administration. The Australian Government plays a crucial role in supporting diabetes management through various programs and subsidies, ensuring access to affordable and high-quality diabetes care solutions. The market is consolidated, with major players like Insulet Corporation, Ypsomed, and Novo Nordisk leading innovations in insulin delivery technologies.

The impact of diabetes on the Australian population is significant, with a rising number of cases and associated health complications. The market's growth is further fueled by the need for effective diabetes management solutions, especially among vulnerable populations such as Aboriginal and Torres Strait Islander Australians. The COVID-19 pandemic highlighted the importance of maintaining diabetes care continuity, prompting a focus on self-management and follow-up care. Insulin pumps are expected to register substantial growth due to their ability to improve glycemic control and quality of life for patients. The market's expansion is supported by ongoing research and development efforts by key industry players, aiming to enhance the functionality and accessibility of insulin delivery devices.

Explore More

Australia Insulin Delivery Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Insulin Pumps

      1. 2.1.1 Insulin Pump Devices

      2. 2.1.2 Insulin Pump Reservoirs

      3. 2.1.3 Insulin Infusion sets

    2. 2.2 Insulin Pens

      1. 2.2.1 Cartridges in reusable pens

      2. 2.2.2 Disposable insulin pens

    3. 2.3 Insulin Syringes

    4. 2.4 Insulin Jet Injectors

Australia Insulin Delivery Devices Market Size FAQs

The Australia Insulin Delivery Devices Market size is expected to reach USD 705.52 million in 2024 and grow at a CAGR of 2.40% to reach USD 794.35 million by 2029.

In 2024, the Australia Insulin Delivery Devices Market size is expected to reach USD 705.52 million.

Australia Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)